mecamylamine has been researched along with Abnormalities, Autosome in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lippiello, PM | 1 |
| Beaver, JS | 1 |
| Gatto, GJ | 1 |
| James, JW | 1 |
| Jordan, KG | 1 |
| Traina, VM | 1 |
| Xie, J | 1 |
| Bencherif, M | 1 |
1 review available for mecamylamine and Abnormalities, Autosome
| Article | Year |
|---|---|
TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity.
Topics: Animals; Antidepressive Agents; Chromosome Aberrations; Dogs; ERG1 Potassium Channel; Ether-A-Go-Go | 2008 |